rhenium nanoliposome: investigational radiotherapy for recurrent glioblastoma
Published 3 years ago • 22K plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
2:58
plus therapeutics rhenium nanoliposome: investigational radiotherapy for recurrent glioblastoma
-
28:53
a promising new radiotherapy for recurrent glioblastoma
-
10:11
respect™ clinical trial - recurrent glioblastoma patient interview
-
0:33
what is the 186rnl radiotherapeutic and how does it work?
-
0:21
respect-gbm clinical trial
-
0:34
what is glioblastoma? annual incidence, current treatments, and challenges.
-
59:13
plus therapeutics announces positive interim data from respect™ clinical trial in glioblastoma
-
1:12
why is 186rnl potentially a novel radiotherapeutic?
-
0:38
plus therapeutics announces webinar to present respect™ glioblastoma clinical trial update
-
2:57
plus therapeutics announces plans for treating pediatric brain cancer
-
0:40
plus therapeutics strengthens commercial rnl supply chain with 10-year exclusivity agreement
-
19:09
infusing rhenium nanoliposomes into glioblastoma showing high efficacy eradicating these brain t...
-
1:04
plus therapeutics successfully treats first patient in cohort 8 of respect-gbm phase 1/2a trial
-
1:34
plus therapeutics reports first quarter 2021 financial results and business highlights
-
1:19
glioblastoma: a closer look
-
4:46
treatment options in recurrent glioblastoma